Get all your news in one place.

100’s of premium titles.
One app.

Start reading

Get all your news in one place.

100’s of premium titles. One news app.

Start reading

The Latest Breaking News from Abbott

3 Passive Income Stocks To Scoop Up Now

These three stocks have earned the title of Dividend Kings by consistently increasing dividends for at least 50 years.

Barchart

U.S. govt protected baby formula makers

The U.S. government repeatedly used its muscle to advance the interests of large baby formula companies

Salon

Why Abbott's Formula-Related Sell-Off Could Be A Buying Opportunity, Says Analyst

Abbott stock tumbled to a month-low Friday after an Illinois jury ordered Reckitt Benckiser to pay $60 million in an infant formula lawsuit.

Investors Business Daily

From analysis to the latest developments in health,
read the most diverse news in one place.

Continuous glucose monitors – health fad or the future of wellbeing?

Over the past couple of years, interest in direct-to-consumer applications for continuous glucose monitoring has spiked, but not every expert is convinced these medical devices have a place in the arms of regular, non-diabetic folk.

TechRadar

SECURE 2.0 Act Now Helps Lighten the Burden of Student Loans

Employers can attract talented employees with a new benefit: a matching contribution to an employees’ 401(k) when they make payments on their student debt.

Kiplinger

Dexcom Breaks Out As FDA Clears It To Enter A New Market: Obesity

Dexcom stock popped Wednesday after the FDA cleared its newest body-worn glucose monitor for people who don't require insulin treatment.

Investors Business Daily

10 Best Technology Brands At CES 2024

The final list is not just a win for consumers on the lookout for groundbreaking tech but also serves as an eye-opener to investors searching for scalable tech solutions poised for global impact.

International Business Times

Read news from The Economist, FT, and more,
with one subscription

50 Top Companies By Market Capitalization: The Global Giants

These companies are the ones that dominate the market and will continue to do so should factors remain constant.

International Business Times

Abbott Laboratories Reports Strong Earnings Despite Recent Challenges

Abbott Laboratories' Q4 earnings report and stock performance analysis, highlighting limited growth potential.

Top News

Abbott Labs Skids Within A Saucer Base Despite 'Solid Results'

Abbott's earnings guidance slightly missed expectations at the midpoint Wednesday, and ABT stock fell within a saucer base.

Investors Business Daily

Get all your
news in one place.

100’s of premium titles.
One news app.

Latin Times

Four Measures Taken by New York City's Government to Address the Migrant Crisis

Around 170,000 migrants have arrived in New York City since 2022, putting its shelter system and financial situation under pressure

The Independent UK

Real-time glucose monitoring wearable launches in the UK – here’s how it works

The Abbott Lingo analyses a wearer’s glucose spikes and falls and offers personalised habit suggestions and coaching in response

Barchart

100 Years of Paying Dividends: Why You Need This Healthcare Stock

Dividend growth investors love this boring healthcare stock for three reasons: Growth, financial stability, and 100 years of paying dividends.

The Independent UK

Two babies infected with rare bacteria sometimes found in powdered infant formula

A Kentucky child is dead and a Missouri infant has brain damage from the same kind of bacteria that sparked powdered formula recalls and shortages last year

Get all your
news in one place.

100’s of premium titles.
One news app.

Investors Business Daily

Weight-Loss Drugs Spooked Medical Device Stocks. Did Investors Overreact?

The good times keep rolling for Novo Nordisk and its weight-loss drugs. But it's bad news for some medical device stocks.

Investors Business Daily

Stock Market Struggles As Treasury Yields Soar; Tesla, Nvidia Among Notable Losers: Weekly Review

The major indexes saw significant loses as Treasury yields soared. Tesla tumbled on earnings while Nvidia fell on fresh China chip curbs.

Investors Business Daily

Abbott Shrugs Off 'Tizzy' Over Weight-Loss Drugs, Surging On Beat And Raise

Abbott stock popped Wednesday after shrugging off concerns that new diabetes and weight-loss drugs will undercut its diabetes devices.

Barchart

Worried About a Recession? Protect Your Portfolio With These 3 Resilient Stocks

With geopolitical tensions rising, here are three stocks from different sectors that have the ability to weather this storm.

Investors Business Daily

Why Abbott Says It Won't Be A Casualty Of The Weight-Loss Battle

Abbott stock jumped Thursday after showing patients taking popular diabetes and weight-loss drugs are more compliant with their CGMs.

Fortune

The companies electrifying cars—including Tesla—top Fortune's Change the World list

Fortune's Change the World list is a stong statement that business success can't be measured by financial metrics alone.

Roll Call

After infant formula crisis, lawmakers look to donor milk - Roll Call

Lawmakers want to make donor breast milk more mainstream but advocates warn the alternative comes with risk.

1 2 3 4 5

People

Margaret Kaczor Andrew

10 stories

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.